Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Blood (2008) 111 (10): 4979–4985.

https://doi.org/10.1182/blood-2007-09-110940

Published: 2008

Journal Articles

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Blood (2008) 111 (7): 3531–3539.

https://doi.org/10.1182/blood-2007-08-109231

Published: 2008

Includes: Supplemental data

Journal Articles

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Blood (2006) 109 (1): 112–121.

https://doi.org/10.1182/blood-2006-05-020784

Published: 2006

Includes: Supplemental data

Journal Articles

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

Augusto B. Federici, Claudine Mazurier, Erik Berntorp, Christine A. Lee, Inge Scharrer, Jenny Goudemand, Stephan Lethagen, Ioana Nitu, Gerard Ludwig, Lysiane Hilbert, Pier M. Mannucci

Blood (2004) 103 (6): 2032–2038.

https://doi.org/10.1182/blood-2003-06-2072

Published: 2004

Journal Articles

The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A–like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor

Anne-Sophie Ribba, Lysiane Hilbert, Jean-Maurice Lavergne, Edith Fressinaud, Catherine Boyer-Neumann, Catherine Ternisien, Irène Juhan-Vague, Jenny Goudemand, Jean-Pierre Girma, Claudine Mazurier, Dominique Meyer

Blood (2001) 97 (4): 952–959.

https://doi.org/10.1182/blood.V97.4.952

Published: 2001

Journal Articles

Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female

Rémi Favier, Jean-Maurice Lavergne, Jean-Marc Costa, Claudine Caron, Claudine Mazurier, Michèle Viémont, Marc Delpech, Sophie Valleix

Blood (2000) 96 (13): 4373–4375.

https://doi.org/10.1182/blood.V96.13.4373

Published: 2000

Journal Articles

Conformational changes in the D′ domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment

Sylvie Jorieux, Edith Fressinaud, Jenny Goudemand, Christine Gaucher, Dominique Meyer, Claudine Mazurier, the INSERM Network on Molecular Abnormalities in von Willebrand Disease

Blood (2000) 95 (10): 3139–3145.

https://doi.org/10.1182/blood.V95.10.3139

Published: 2000

NARROW

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A–like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor

Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female

Conformational changes in the D′ domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment

Email alerts

ASH Publications

American Society of Hematology

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A–like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor

Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female

Conformational changes in the D′ domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only